This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase II trial of capecitabine (Xeloda�) + nab-pac...
Clinical trial

Phase II trial of capecitabine (Xeloda�) + nab-paclitaxel (Abraxane�) in patients with metastatic pancreatic cancer

Read time: 1 mins
Last updated:18th Jun 2013
Objective response rate of Capecitabine + Nab-Paclitaxel as first-line chemotherapy in patients with metastatic pancreatic cancer
Category Value
Study start date 2013-06-18

View full details